|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM177796928 |
| 003 |
DE-627 |
| 005 |
20231223151013.0 |
| 007 |
tu |
| 008 |
231223s2007 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0593.xml
|
| 035 |
|
|
|a (DE-627)NLM177796928
|
| 035 |
|
|
|a (NLM)18293521
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a Four new therapies offer hope to patients with congestive heart failure. New medications in various stages of development may provide alternatives to current drugs that relax arteries and reduce fluid retention
|
| 264 |
|
1 |
|c 2007
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 28.02.2008
|
| 500 |
|
|
|a Date Revised 21.10.2016
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Purinergic P1 Receptor Antagonists
|2 NLM
|
| 650 |
|
7 |
|a Vasodilator Agents
|2 NLM
|
| 650 |
|
7 |
|a Vasopressins
|2 NLM
|
| 650 |
|
7 |
|a 11000-17-2
|2 NLM
|
| 773 |
0 |
8 |
|i Enthalten in
|t Heart advisor
|d 1999
|g 10(2007), 8 vom: 21. Aug., Seite 1, 7
|w (DE-627)NLM098274252
|x 1523-9004
|7 nnns
|
| 773 |
1 |
8 |
|g volume:10
|g year:2007
|g number:8
|g day:21
|g month:08
|g pages:1, 7
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 10
|j 2007
|e 8
|b 21
|c 08
|h 1, 7
|